The management of atherosclerotic renal artery stenosis (ARAS) in patients with hypertension has been the topic of great controversy. Major contemporary clinical trials such as the Cardiovascular Outcomes for Renal Artery lesions (CORAL) and Angioplasty and Stenting for Renal Atherosclerotic lesions (ASTRAL) have failed to show significant benefit of revascularization over medical management in controlling blood pressure and preserving renal function. We present here the implications and limitations of these trials and formulate recommendations for management of ARAS.
How to manage hypertension with atherosclerotic renal artery stenosis? / Ricco, Jean Baptiste; Belmonte, Romain; Illuminati, Giulio; Barral, Xavier; Schneider, Fabrice; Chavent, Bertrand. - In: THE JOURNAL OF CARDIOVASCULAR SURGERY. - ISSN 1827-191X. - STAMPA. - 58:2(2017), pp. 329-338. [10.23736/S0021-9509.16.09827-X]
How to manage hypertension with atherosclerotic renal artery stenosis?
ILLUMINATI, Giulio;
2017
Abstract
The management of atherosclerotic renal artery stenosis (ARAS) in patients with hypertension has been the topic of great controversy. Major contemporary clinical trials such as the Cardiovascular Outcomes for Renal Artery lesions (CORAL) and Angioplasty and Stenting for Renal Atherosclerotic lesions (ASTRAL) have failed to show significant benefit of revascularization over medical management in controlling blood pressure and preserving renal function. We present here the implications and limitations of these trials and formulate recommendations for management of ARAS.File | Dimensione | Formato | |
---|---|---|---|
Ricco_ Renal-artery_2017.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
3.82 MB
Formato
Adobe PDF
|
3.82 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.